[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"stock-detail-RPRX":3,"homepage-market-summary":35,"stock-stats-RPRX":179},{"ticker":4,"date":5,"profile":6,"dividend":15,"quote":19},"RPRX","2026-10-08",{"name":7,"exchange":8,"sector":9,"industry":10,"description":11,"ceo":9,"employees":12,"headquarters":13,"founded":9,"is_fund":14,"issuer":9,"category":9},"Royalty Pharma plc Class A Ordinary Shares","Nasdaq",null,"PHARMACEUTICAL PREPARATIONS","Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.","100","New York, NY",false,{"dividend_yield":16,"annual_dividend":17,"frequency":18,"next_ex_date":9},1.6723,0.94,"Quarterly",{"close":20,"open":21,"high":22,"low":23,"prev_close":24,"change":25,"percent_change":26,"volume":27,"transactions":28,"vwap":29,"high_52w":30,"low_52w":31,"avg_volume_52w":32,"range_52w_percent":33,"record_count":34},56.21,56.57,56.71,55.13,56.76,-0.55,-0.97,2535375.206429,31441,55.9856,64.38,35.23,3503497.8629530556,72,1587,{"status":36,"indices":37,"watchlist":81,"sectors":103,"benchmarks":158},"success",[38,45,52,60,67,74],{"symbol":39,"name":40,"price":41,"change":42,"pct_change":43,"is_up":14,"sparkline":44,"date":5},"SPX","S&P 500",7765.36,-36.41,-0.47,"0.0,10.5 2.3,12.4 4.6,14.2 6.9,16.0 9.3,11.5 11.6,10.8 13.9,4.8 16.2,4.8 18.5,7.9 20.8,8.0 23.2,6.0 25.5,9.1 27.8,9.8 30.1,10.8 32.4,10.0 34.7,7.0 37.1,4.4 39.4,2.0 41.7,2.9 44.0,4.8",{"symbol":46,"name":47,"price":48,"change":49,"pct_change":50,"is_up":14,"sparkline":51,"date":5},"NDX","NASDAQ 100",30725.81,-434.27,-1.39,"0.0,13.4 2.3,14.8 4.6,16.0 6.9,16.0 9.3,12.9 11.6,11.7 13.9,6.5 16.2,5.0 18.5,6.6 20.8,6.6 23.2,5.8 25.5,7.8 27.8,7.4 30.1,7.0 32.4,6.4 34.7,4.6 37.1,2.9 39.4,2.0 41.7,2.4 44.0,5.1",{"symbol":53,"name":54,"price":55,"change":56,"pct_change":57,"is_up":58,"sparkline":59,"date":5},"DJI","DOW JONES",51232,52,0.1,true,"0.0,2.0 2.3,3.3 4.6,6.0 6.9,11.3 9.3,8.7 11.6,9.5 13.9,6.4 16.2,8.0 18.5,10.9 20.8,12.3 23.2,8.2 25.5,11.2 27.8,12.3 30.1,16.0 32.4,15.8 34.7,13.7 37.1,13.0 39.4,10.8 41.7,13.7 44.0,13.3",{"symbol":61,"name":62,"price":63,"change":64,"pct_change":65,"is_up":14,"sparkline":66,"date":5},"COMP","NASDAQ Composite",27193.34,-345.35,-1.25,"0.0,12.9 2.3,14.2 4.6,16.0 6.9,16.0 9.3,12.2 11.6,11.3 13.9,6.1 16.2,5.1 18.5,7.7 20.8,7.7 23.2,6.6 25.5,8.7 27.8,8.9 30.1,8.4 32.4,8.3 34.7,5.5 37.1,3.1 39.4,2.0 41.7,2.5 44.0,5.5",{"symbol":68,"name":69,"price":70,"change":71,"pct_change":72,"is_up":14,"sparkline":73,"date":5},"RUT","RUSSELL 2000",2775.7,-1.3,-0.05,"0.0,2.0 2.3,4.1 4.6,6.6 6.9,8.1 9.3,6.3 11.6,7.9 13.9,6.1 16.2,4.1 18.5,10.6 20.8,10.9 23.2,10.6 25.5,13.0 27.8,14.2 30.1,15.6 32.4,14.2 34.7,11.1 37.1,8.8 39.4,11.3 41.7,15.8 44.0,16.0",{"symbol":75,"name":76,"price":77,"change":78,"pct_change":79,"is_up":58,"sparkline":80,"date":5},"VIX","CBOE VIX",15.41,0.33,2.19,"0.0,9.5 2.3,4.4 4.6,4.0 6.9,2.0 9.3,11.1 11.6,13.6 13.9,13.4 16.2,16.0 18.5,12.1 20.8,10.2 23.2,13.4 25.5,8.6 27.8,8.7 30.1,7.5 32.4,7.3 34.7,11.6 37.1,10.8 39.4,12.8 41.7,12.5 44.0,11.2",[82,89,96],{"symbol":83,"name":84,"price":85,"change":86,"pct_change":87,"is_up":14,"sparkline":88,"date":5},"NVDA","NVIDIA Corp",230.48,-6.99,-2.94,"0.0,16.0 7.3,12.8 14.7,8.8 22.0,2.4 29.3,2.0 36.7,4.3 44.0,13.3",{"symbol":90,"name":91,"price":92,"change":93,"pct_change":94,"is_up":58,"sparkline":95,"date":5},"AAPL","Apple Inc",340.43,3.76,1.12,"0.0,12.3 7.3,16.0 14.7,11.3 22.0,12.4 29.3,11.4 36.7,7.2 44.0,2.0",{"symbol":97,"name":98,"price":99,"change":100,"pct_change":101,"is_up":14,"sparkline":102,"date":5},"TSLA","Tesla Inc",375,-2.81,-0.74,"0.0,15.6 7.3,16.0 14.7,7.3 22.0,3.0 29.3,2.0 36.7,3.5 44.0,5.0",[104,109,114,119,124,129,134,138,143,148,153],{"name":105,"etf":106,"change":107,"price":108,"is_up":14},"Technology","XLK",-1.79,197.78,{"name":110,"etf":111,"change":112,"price":113,"is_up":58},"Financials","XLF",0.89,54.23,{"name":115,"etf":116,"change":117,"price":118,"is_up":14},"Healthcare","XLV",-0.39,168.16,{"name":120,"etf":121,"change":122,"price":123,"is_up":58},"Consumer Cycl","XLY",0.31,111.7,{"name":125,"etf":126,"change":127,"price":128,"is_up":58},"Consumer Staples","XLP",2.11,83.42,{"name":130,"etf":131,"change":132,"price":133,"is_up":58},"Energy","XLE",2.97,65.24,{"name":135,"etf":136,"change":78,"price":137,"is_up":58},"Industrials","XLI",168.4,{"name":139,"etf":140,"change":141,"price":142,"is_up":58},"Materials","XLB",0.59,49.27,{"name":144,"etf":145,"change":146,"price":147,"is_up":58},"Real Estate","XLRE",0.69,40.85,{"name":149,"etf":150,"change":151,"price":152,"is_up":14},"Utilities","XLU",-0.19,41.07,{"name":154,"etf":155,"change":156,"price":157,"is_up":58},"Comm Services","XLC",0.73,112.07,[159,164,169,174],{"ticker":160,"name":161,"price":162,"change":163,"is_up":14},"SPY","SPDR S&P 500 ETF",773.97,-0.42,{"ticker":165,"name":166,"price":167,"change":168,"is_up":14},"QQQ","Invesco QQQ Trust",747.58,-1.34,{"ticker":170,"name":171,"price":172,"change":173,"is_up":58},"DIA","SPDR Dow Jones ETF",511.65,0.12,{"ticker":175,"name":176,"price":177,"change":178,"is_up":14},"IWM","iShares Russell 2000",277.63,-0.03,{"ticker":4,"company_name":7,"current_price":20,"data_notice":180,"valuation":181,"dates":184,"share_statistics":187,"valuation_ratios":190,"enterprise_valuation":191,"financial_position":192,"financial_efficiency":194,"taxes":196,"price_statistics":197,"income_statement":204,"balance_sheet":206,"cash_flow":207,"margins":209,"dividends":210,"analyst_forecast":213,"fair_value":215,"splits":217,"fundamentals_available":14},"Dividend history, analyst price targets, ownership breakdown, short interest, stock splits, beta, WACC and Altman\u002FPiotroski scores are not available from any data source Bullzeno currently integrates, so those fields are omitted (null) rather than estimated.",{"market_cap":182,"enterprise_value":9,"summary":183},25452052983.039997,"RPRX has a market cap of $25,452,052,983.04.",{"latest_fiscal_period_end":9,"earnings_date":9,"ex_dividend_date":185,"summary":186},"2026-08-14","No fundamental filing dates are available for this symbol.",{"shares_outstanding":188,"owned_by_insiders":9,"owned_by_institutions":9,"summary":189},445277344,"RPRX has 445,277,344 shares outstanding.",{"pe_ratio":9,"ps_ratio":9,"pb_ratio":9,"pfcf_ratio":9,"pocf_ratio":9},{"ev_earnings":9,"ev_sales":9,"ev_ebitda":9,"ev_ebit":9,"ev_fcf":9},{"current_ratio":9,"debt_equity":9,"debt_ebitda":9,"debt_fcf":9,"summary":193},"Balance sheet data is not available for this symbol.",{"roe":9,"roa":9,"revenue_per_employee":9,"profit_per_employee":9,"employee_count":195,"asset_turnover":9},100,{"income_tax":9},{"beta_5y":9,"price_change_52w":198,"ma_50":199,"ma_200":200,"rsi_14":201,"avg_volume_20d":202,"summary":203},56.05,59.2,51.44,27.73,2935598,"The stock price has changed by +56.05% in the last 52 weeks.",{"revenue":9,"gross_profit":9,"operating_income":9,"pretax_income":9,"net_income":9,"ebitda":9,"ebit":9,"eps":9,"summary":205},"Income statement data is not available for this symbol.",{"cash_and_equiv":9,"total_debt":9,"net_cash":9,"net_cash_per_share":9,"equity_book_value":9,"book_value_per_share":9,"working_capital":9,"summary":193},{"operating_cash_flow":9,"capital_expenditures":9,"depreciation_amortization":9,"net_borrowing":9,"free_cash_flow":9,"fcf_per_share":9,"summary":208},"Cash flow data is not available for this symbol.",{"gross_margin":9,"operating_margin":9,"pretax_margin":9,"profit_margin":9,"ebitda_margin":9,"fcf_margin":9},{"dividend_per_share":17,"dividend_yield":211,"earnings_yield":9,"fcf_yield":9,"summary":212},1.67,"RPRX pays a quarterly dividend of $0.235 per share ($0.94 a year, 1.67% yield at the latest close).",{"price_target":9,"price_target_diff":9,"consensus":9,"analyst_count":9,"summary":214},"Analyst price targets and consensus ratings are not available.",{"lynch_fair_value":9,"lynch_upside":9,"graham_number":9,"graham_upside":9,"summary":216},"Graham Number and Peter Lynch Fair Value are textbook valuation formulas applied to this company's real reported EPS and book value; they are estimates, not price targets or guarantees.",{"last_split_date":9,"split_type":9,"split_ratio":9,"summary":218},"Stock split history is not available for this symbol."]